Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2834
https://www.abbvie.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
- Apr 19th, 2024 8:11 pm
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
- Apr 19th, 2024 2:00 pm
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
- Apr 19th, 2024 1:15 pm
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
- Apr 18th, 2024 7:44 pm
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
- Apr 18th, 2024 4:18 pm
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
- Apr 18th, 2024 12:31 pm
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
- Apr 18th, 2024 10:30 am
AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
- Apr 17th, 2024 9:45 pm
UPDATE 1-US FDA warns of harmful reactions to fake Botox injections
- Apr 16th, 2024 2:21 pm
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
- Apr 16th, 2024 1:00 pm
Johnson & Johnson (JNJ) Q1 Earnings Top Estimates
- Apr 16th, 2024 11:30 am
12 Best Dividend Stocks with High Upside Potential
- Apr 16th, 2024 7:02 am
Roche reports survival data for new dual-acting lymphoma drug
- Apr 15th, 2024 11:57 am
Is AbbVie a Millionaire Maker?
- Apr 14th, 2024 5:23 am
What's Going On AbbVie Stock On Friday?
- Apr 12th, 2024 8:19 pm
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
- Apr 12th, 2024 11:30 am
AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
- Apr 11th, 2024 9:45 pm
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
- Apr 11th, 2024 5:10 pm
AbbVie Inc's Dividend Analysis
- Apr 11th, 2024 11:02 am
Are You Looking for a High-Growth Dividend Stock?
- Apr 10th, 2024 3:45 pm
Scroll